small molecule

PREPOPIK

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyFerring PharmaceuticalsView the full company profile on CliffBio

Drug detail

Brand namePREPOPIK
Active ingredientCITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Strength12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2012
Marketing statusDISCN

Listed patents

PatentExpiresType
8450338October 2028product
8481083October 2028product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PREPOPIK patent cliff — loss of exclusivity October 2028 | CliffBio